02.12.2014 Views

Innovation in European healthcare – what can Sweden learn? - LIF

Innovation in European healthcare – what can Sweden learn? - LIF

Innovation in European healthcare – what can Sweden learn? - LIF

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

The key players all face challenges <strong>in</strong> the current<br />

health care system<br />

The federal<br />

state<br />

The federal state must conta<strong>in</strong> the expenditure of the SHI:s and therefore the ancillary wage costs<br />

Through the different legislations this was achieved: In the end of 2012 the GKV and the<br />

Gesundheitsfonds together had f<strong>in</strong>ancial reserves of around 23,5 bn €<br />

The federal state must conta<strong>in</strong> the possibility to get care <strong>in</strong> all parts of Germany, also <strong>in</strong> rarely<br />

populated areas (<strong>in</strong>patient and outpatient care)<br />

Implementation of <strong>in</strong>novations <strong>in</strong>to the health care sector is an on-go<strong>in</strong>g discussion topic<br />

SHI (Die<br />

Krankenkassen)<br />

The Health Care<br />

Providers<br />

From 2009 and onward the central government has set the contribution %age nationwide (15,5%) -<br />

contributions then have to be paid <strong>in</strong>to a new health funds, and SHI will get money through the<br />

health funds lead<strong>in</strong>g to mergers between SHI funds. (First examples: merger between TK und IKK<br />

direkt; KKH and Allianz BKK -> seen for the first time <strong>in</strong> Germany)<br />

The new additional contributions directly from the <strong>in</strong>surees, if an SHI-fund does not get enough<br />

money from the health funds, lead to massive loss of <strong>in</strong>surees (example DAK), because <strong>in</strong>sured<br />

persons have the right to change SHI funds, when additional contributions apply; this has led to a<br />

very cautious, risk-avoid<strong>in</strong>g f<strong>in</strong>ancial policy of all SHI funds<br />

It is crucial for the hospitals to adapt to the DRG system <strong>in</strong> a profitable way<br />

Price and cost development do not match – costs are grow<strong>in</strong>g faster than the prices<br />

Pharmaceutical companies have to adopt their bus<strong>in</strong>ess strategy to new rules for <strong>in</strong>novative drugs<br />

MedTech companies compla<strong>in</strong> about the time gap before an <strong>in</strong>novation is properly paid with<strong>in</strong> the<br />

SHI<br />

36

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!